Therapeutic Opportunities with Pharmacological Inhibition of CD38 with Isatuximab

por Martin, Thomas G., Corzo, Kathryn, Chiron, Marielle, van de Velde, Helgi, Abbadessa, Giovanni, Campana, Frank, Solanki, Malini, Meng, Robin, Lee, Helen, Wiederschain, Dmitri, Zhu, Chen, Rak, Alexey, Anderson, Kenneth C.
Publicado 2019

Targeting CD38 and PD-1 with isatuximab plus cemiplimab in patients with advanced solid malignancies: results from a phase I/II open-label, multicenter study

por Zucali, Paolo Andrea, Lin, Chia-Chi, Carthon, Bradley C, Bauer, Todd M, Tucci, Marcello, Italiano, Antoine, Iacovelli, Roberto, Su, Wu-Chou, Massard, Christophe, Saleh, Mansoor, Daniele, Gennaro, Greystoke, Alastair, Gutierrez, Martin, Pant, Shubham, Shen, Ying-Chun, Perrino, Matteo, Meng, Robin, Abbadessa, Giovanni, Lee, Helen, Dong, Yingwen, Chiron, Marielle, Wang, Rui, Loumagne, Laure, Lépine, Lucie, de Bono, Johann
Publicado 2022

A phase 1/2, open‐label, multicenter study of isatuximab in combination with cemiplimab in patients with lymphoma

por Carlo‐Stella, Carmelo, Zinzani, Pier Luigi, Sureda, Anna, Araújo, Luis, Casasnovas, Olivier, Carpio, Cecilia, Yeh, Su‐Peng, Bouabdallah, Krimo, Cartron, Guillaume, Kim, Won Seog, Cordoba, Raul, Koh, Youngil, Re, Alessandro, Alves, Daniela, Chamuleau, Martine, Le Gouill, Steven, López‐Guillermo, Armando, Moreira, Ilídia, van der Poel, Marjolein W. M., Abbadessa, Giovanni, Meng, Robin, Ji, Ran, Lépine, Lucie, Saleem, Rao, Ribrag, Vincent
Publicado 2022

S259: SAR444245, A NON-ALPHA IL2, RESCUES CHRONIC ANTIGEN- AND CAR-DRIVEN T-CELL DYSFUNCTION

por Sheikh, Irtiza, Choi, Ahyun, Reville, Patrick, Henderson, Jared, Rojas, Estela, Le, Cuong, Okwuchi, Chizitara, Carrio, Robert, Pate, Nathan, Malley, Katie, Bangari, Dinesh, Gavigan, Julie-Ann, Shi, Chaomei, Liu, Bing, Zhang, Yu-An, Byers, Tony, Sassoon, Ingrid, Cucchetti, Margot, Wang, Rui, Agarwal, Maria, Abbadessa, Giovanni, Meng, Robin, Meibalan, Elamaran, Powers, Laura, Cao, James, Ying, Xiaoyou, Balko, Kelly, Yu, Qunyan, Jiao, Jing, Cortez-Retamozo, Virna, Sidhu, Sukhvinder, Shaffer, Donald, LI, Xiangming, Green, Michael
Publicado 2023